About PHA Staff

This author has not yet filled in any details.
So far PHA Staff has created 223 blog entries.

Join New Fundraising Walk in Northern Virginia on May 4

2019-03-21T15:36:08+00:00 March 21st, 2019|

The Pulmonary Hypertension Association (PHA) will host the inaugural Northern Virginia Walk on Saturday, May 4, in Alexandria, Va. The walk offers an opportunity for patients, caregivers, friends, family and medical professionals to gather for a common goal: raising funds to help support those affected by pulmonary hypertension (PH) and ultimately find a cure.

New Online Tool Simplifies Clinical Trial Search

2019-03-13T20:28:27+00:00 March 13th, 2019|

The Pulmonary Hypertension Association (PHA) is pleased to announce the launch of its new Clinical Trial Finder, now available in the research section of the PHA website, PHAssociation.org. PHA provides this tool to help participants learn more about ongoing PH research. The tool includes filters to narrow search results to fit an individual’s personal needs.

PHA Helps Spread Awareness of Blood Clots and Relationship to PH

2019-03-13T20:27:11+00:00 March 13th, 2019|

The Pulmonary Hypertension Association (PHA) is pleased to join The National Blood Clot Alliance and other health care organizations around the nation to spread the word about blood clots during Blood Clot Awareness Month (BCAM) in March. This year’s theme is “Together We Can Increase Awareness and Save Lives.” BCAM’s goal is to bring

Updated REVEAL Risk Calculator Improves Accuracy of PAH Survival Predictions

2019-03-07T18:51:45+00:00 March 7th, 2019|

A team of researchers has increased the accuracy of a tool used to predict survival for individuals with World Health Organization Group 1 PH (pulmonary arterial hypertension or PAH). CHEST Journal, the official publication of the American College of Chest Physicians, has published a study by Raymond L. Benza, M.D., a cardiologist at Allegheny

Second Generic Tadalafil Product Announced

2019-03-07T18:53:09+00:00 March 7th, 2019|

Questions to Consider When Choosing Between Brand and Generic Therapy Teva Pharmaceutical Industries recently announced the launch of ALYQ ™ (tadalafil), a generic version of the drug Adcirca®. Mylan launched the first generic tadalafil in August. How an individual with pulmonary hypertension (PH) is impacted by the availability of generic therapy may depend on

Living With Two Rare Diseases

2019-02-28T22:28:56+00:00 February 28th, 2019|

“Rare Disease Day is not just about PH; it is also a recognition of the many rare diseases for which resources and funding are often limited.” By Shan Hardwick “I have PH, caused by scleroderma. I had symptoms of a scleroderma-related syndrome for years, but no one put them together for a